Locations
England, UK · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2017
Pear Bio is a Boston and London-based AI-enabled biotech company. We develop functional precision medicine-guided therapeutics for patients with hard-to-treat cancers. We take tumor biopsies from cancer patients, turn them into 3D immune-microtumors and test various treatment options side-by-side to stratify responders and non-responders. We then characterize the remaining patient tissue/blood to identify new targets and develop therapeutics for patient populations with high unmet need. We have 2 internal drug discovery programs, and we are using our 3D immune-microtumor platform to position our drug candidates in the right indications/populations and in smarter combination therapies.
Something looks off?On-site & Remote